Letters/Replies
Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease
Oswaldo Lorenzo-Betancor MD, PhD,
Oswaldo Lorenzo-Betancor MD, PhD
Departments of Neuroscience, Mayo Clinic, Jacksonville, FL
Search for more papers by this author Zbigniew K. Wszolek MD,
Zbigniew K. Wszolek MD
Departments of Neurology, Mayo Clinic, Jacksonville, FL
Search for more papers by this author Owen A. Ross PhD,
Owen A. Ross PhD
Departments of Neuroscience, Mayo Clinic, Jacksonville, FL
Search for more papers by this author
Oswaldo Lorenzo-Betancor MD, PhD,
Oswaldo Lorenzo-Betancor MD, PhD
Departments of Neuroscience, Mayo Clinic, Jacksonville, FL
Search for more papers by this author Zbigniew K. Wszolek MD,
Zbigniew K. Wszolek MD
Departments of Neurology, Mayo Clinic, Jacksonville, FL
Search for more papers by this author Owen A. Ross PhD,
Owen A. Ross PhD
Departments of Neuroscience, Mayo Clinic, Jacksonville, FL
Search for more papers by this author
First published: 17 December 2015
No abstract is available for this article.
Additional supporting information can be found in the online version of this article.
Filename |
Description |
ana24581-sup-0001-suppinfo.docx26.6 KB |
Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Tell-Marti G, Puig-Butille JA, Potrony M, et al. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease. Ann Neurol 2015; 77: 889–894.
- 2Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology 2011; 76: 2002–2009.
- 3Ranganathan S, Dexter DW, Benetatos CA, Hudes GR. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochim Biophys Acta 1998; 1395: 237–245.
- 4Dong J, Gao J, Nalls M, et al. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease. Neurobiol Aging 2014; 35: 1512.e5–1512.e10.
- 5Lubbe SJ, Escott-Price V, Brice A, et al. Is the MC1R variant p.R160W associated with Parkinson's? Ann Neurol 2015 Sep 21.
- 6Reyniers L, Del Giudice MG, Civiero L, et al. Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways. J Neurochem 2014; 131: 239–250.